Clear Cell Adenocarcinoma
2 clinical trials · Condition
◉ Watch Clear Cell Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00565851) | National Cancer Institute (NCI) | 2007-12-06 |
Track Clear Cell Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.